Three-year results from a preclinical implantation study of a long-term resorbable surgical mesh with time-dependent mechanical characteristics
- First Online:
- Cite this article as:
- Hjort, H., Mathisen, T., Alves, A. et al. Hernia (2012) 16: 191. doi:10.1007/s10029-011-0885-y
- 1.4k Downloads
The purpose of this study was to evaluate the biocompatibility, local tissue effects and performance of a synthetic long-term resorbable test mesh (TIGR® Matrix Surgical Mesh) compared to a non-resorbable polypropylene control mesh following implantation in a sheep model.
Full-thickness abdominal wall defects were created in 14 sheep and subsequently repaired using test or control meshes. Sacrifices were made at 4, 9, 15, 24 and 36 months and results in terms of macroscopic observations, histology and collagen analysis are described for 4, 9, 15, 24 and 36 months.
The overall biocompatibility was good, and equivalent in the test and control meshes while the resorbable mesh was characterized by a collagen deposition more similar to native connective tissue and an increased thickness of the integrating tissue. The control polypropylene mesh provoked a typical chronic inflammation persistent over the 36-month study period. As the resorbable test mesh gradually degraded it was replaced by a newly formed collagen matrix with an increasing ratio of collagen type I/III, indicating a continuous remodeling of the collagen towards a strong connective tissue. After 36 months, the test mesh was fully resorbed and only microscopic implant residues could be found in the tissue.
This study suggests that the concept of a long-term resorbable mesh with time-dependent mechanical characteristics offers new possibilities for soft tissue repair and reinforcement.
KeywordsPreclinical Hernia Mesh Implant Resorbable Absorbable Degradable Soft tissue Collagen
Surgical meshes have been used routinely for various soft tissue reinforcement applications since the introduction of Dacron® (polyethylene terephthalate, PET) and Marlex® (polypropylene, PP) in the late 1950s [1, 2]. For hernia repair, polypropylene meshes in particular have been considered the standard material for fabrication of prosthetic meshes used for the tension-free hernia repair described by Lichtenstein et al.  in 1989 as well as for other surgical techniques. The inflammatory responses to the more frequently used mesh products have been investigated on human explants by Klinge et al. , who confirm the view that mesh materials used for soft tissue reinforcement elicit a chronic inflammatory response that is persistent over time. Histological observations describe an implanted permanent mesh, typically characterized by a foreign body granuloma adjacent to the mesh fiber and a surrounding collagen capsule that shields the host from the foreign material. It is reasonable to assume that this chronic inflammatory process impairs normal wound healing and tissue regeneration  but it may still be acceptable in the light of the proposed function of permanent implants, the purpose of which being mainly restoration of mechanical functionality.
In order to improve the outcome of the use of permanent meshes it has further been suggested and shown that decreasing the amount of permanent material implanted can be beneficial for patients [6, 7, 8]. A plausible next step would be the use of resorbable or degradable mesh products that function as scaffolds and are gradually replaced by functional connective tissue. Products made from enzymatically degradable collagen of xenogenic or allogenic origin have been used for this purpose but with questionable outcomes in terms of benefit versus the high cost . Synthetic meshes made of glycolide and a small percentage of trimethylene carbonate or lactide are characterized by a fast degradation leading to a fast decline in mechanical properties. Nonetheless, such meshes have been used successfully in applications where no real load support is required over any significant period of time, such as spleen preservation [10, 11] or for temporary support of abdominal wall reconstructions . Initial short-term results of hernia repair using quick-degrading meshes have also recently been published .
A new approach to abdominal wall repair and soft tissue reinforcement makes use of a mesh that maintains adequate mechanical strength and subsequently resorbs completely over a longer period of time, allowing the body to rebuild a more functional connective tissue. Early preclinical experiences have been published by both de Tayrac et al. [14, 15] and Klinge et al.  but no successful long-term follow-up has been made available. The purpose of this study was to evaluate the mechanical performance and histopathological response of a synthetic long‐term resorbable mesh with a novel time-dependent mechanical behavior, TIGR® Matrix Surgical Mesh (test), compared to a nonresorbable polypropylene mesh (control) during long-term functional implantation in sheep abdominal wall.
Materials and methods
TIGR® Matrix Surgical Mesh is a macroporous multifilament surgical mesh, knitted from two different synthetic resorbable fibers, possessing different degradation characteristics. The first, fast-degrading fiber, is a co-polymer of glycolide, lactide and trimethylene carbonate. The second, slow-degrading fiber, is a co-polymer of lactide and trimethylene carbonate. Both fibers degrade by bulk hydrolysis once implanted, resulting in decreasing strength retention followed by mass loss of the fibers. The mesh maintains more than 50% of its initial strength for 6 months and is completely resorbed after approximately 3 years. When the fast-degrading fiber starts to lose its mechanical strength, at around 2 weeks following implantation, the mesh changes its knitted configuration and gradually becomes more mechanically compliant. This time-dependent mechanical characteristic is thought to enable an increasing load transfer from the mesh to the new connective tissue that integrates with it, thereby mechanically stimulating increased load-directed collagen remodeling .
During a 10-day observation period following surgery, the animals were observed daily for any clinical abnormalities. During this period, the animals were housed in a controlled environment. Following the observation period, all animals were transferred to a farm setting where the environmental conditions were uncontrolled. All conditions conformed to the European requirements for farm animals (EEC Directive 86/609).
Animals were sacrificed using a lethal injection of pentobarbital solution at designated intervals (4, 9, 15, 24 and 36 months), and macroscopic observations of the sites were performed. For all sites, macroscopic degradation of the meshes, local signs of irritation (hemorrhage, necrosis, exudate, neovascularization, degradation of the mesh) and any adhesions between the mesh and the abdominal structures were scored. All the test and control meshes were harvested. After labeling and fixation in 10% buffered formalin solution, specimens were dehydrated in alcohol solutions of increasing concentration, cleared in xylene and embedded in paraffin. Sections were prepared and stained with Masson’s trichrome and hematoxylin-eosin-safranin (HES). Histological slides were observed under a Leica DMR microscope, equipped with a Leica DFC 420C digital camera. Qualitative and semi-quantitative histological evaluation of the local tolerance and material degradation of each implanted site was performed by a qualified pathologist. The scale used was 0: absent, 1: slight, 2: moderate, 3: marked, 4: severe.
Test and control specimens along with an untreated sheep abdominal wall were also sampled for scanning electron microscopy (SEM) at 4 and 9 months. These samples were post-fixed in buffered glutaraldehyde solution after fixation in buffered formalin solution, then dehydrated in 20% acetone solution and treated with gold palladium. SEM was performed using a Hitachi S800 microscope under 15 keV. Pictures were taken in the areas of interest. SEM was conducted to evaluate tissue integration of the devices as well as collagen penetration, distribution, maturity and material degradation.
In order to differentiate between collagen types I and III, paraffin sections of 5 μm in thickness were stained according to the technology of Junqueira  and analyzed under cross-polarization microscopy (CPM). Collagen type I appeared as red–orange shades whereas collagen type III displayed pale-green color. Sections of rat spleen and lymph nodes, rich in collagen III  were prepared under the same conditions and served as controls to accurately set the angle of polarization before grading collagen type III. Abundant in normal skin tissue, collagen type I was recognized easily in the implanted sites.
No defect recurrences were observed throughout the course of the study. One sheep developed an infection at the implanted site and was euthanized and replaced by a reserve animal. Within the first month after surgery, abdominal swelling was observed in eight sheep that otherwise showed good general health status. The swelling was likely due to seroma formation provoked by the rather extensive dissection needed to fit four implants on each animal. Five of these sheep showed hyperthermia and received antibiotics for 4 days. Spontaneous regression was observed, except for one animal on which punctures were performed under sterile conditions. After these punctures, spontaneous regression was observed.
At all time points, the macroscopic evaluations showed no local adverse effects for either the test or control meshes, and no biologically significant differences were ever observed macroscopically. For both test and control, the mesh-tissue complex showed early neovascularization and the meshes were well integrated into fibrous connective tissue. Some differences between individual animals were noted at all time points. In general, the control mesh was easier to locate due to its stiffness as compared to the test mesh, where the mesh-tissue complex was difficult to differentiate from the intact abdominal wall upon palpation of the sites. This was more evident at the 24- and 36-month sacrifices as the polypropylene control mesh was stiff, yet not well integrated and the tissue layers were easily separated from the mesh following explantation. As expected, the control mesh never showed any signs of degradation whereas the first fiber of the test meshes was completely degraded after 4 months and all test meshes were macroscopically undetectable at 36 months.
At 15 and 24 months, the control mesh showed a slight chronic inflammatory reaction. A moderate grade of colonization and slight grade of encapsulation was evident, along with a marked grade of integration of the fibers (Fig. 4b). The test mesh induced an inflammatory reaction qualitatively and quantitatively higher than that of the control mesh, due mainly to a higher recruitment of phagocytotic cells around and between the multifilaments (Fig. 4c). This is part of the degradation process  as the fibers constituting the multifilament displayed evidence of degradation under polarized light. Collagen deposition seemed to be an ongoing process 15 months post implantation.
The test mesh was fully degraded at 36 months and replaced by a connective tissue of variable thickness, and only a few implant residues were observed (Fig. 5b). The control mesh showed no signs of degradation at 36 months after implantation. The inflammatory response to the test mesh had decreased significantly between the 24 and 36 months time points and was clearly lower compared to the control group at 36 months. Only a few macrophages and giant cells showing the intracytoplasmic presence of material debris could be observed. The general connective tissue layer formed was thicker around the test mesh as compared to the control.
Scanning electron microscopy
The thickness of the native abdominal wall was approximately 5 mm, with normal layers of muscle, fat and connective tissue. The control mesh showed a wall thickness of approximately 1.3 mm after 9 months, whereas the test specimen revealed a newly formed abdominal wall of approximately 6 mm. At 4 and 9 months, both test and control specimens showed a well-integrated mesh without signs of encapsulation. The collagen surrounding the filaments was mature with marked signs of remodeling and maturity. These findings were consistent at 24 and 36 months.
In the early phase of wound healing, granulation tissue rich in collagen type III, which is characterized by weak tensile properties, is deposited. Later in the wound healing process collagen type III is replaced by collagen type I characterized by increased tensile properties [21, 22]. In an attempt to determine the ratio between collagen types I and III, selected histology sections from the 9-month observation period were stained according to the method described by Junquiera . The result revealed a slightly higher ratio of collagen type I at the test sites associated with a higher rate of connective tissue maturation when compared to the control implants.
Based on the above results, a more thorough histomorphometric analysis of the collagen ratio in some of the slides originating from 15, 24 and 36 months observations was performed.
Specimens were taken only from animals carrying both test and control meshes in order to compensate for individual variability.
For the test sites the collagen was found to integrate well within the mesh after 24 months and could also be found between individual fiber bundles as well as surrounding the mesh. At 36 months the mesh was no longer visible and the resorbed fiber bundles were fully replaced by new collagen-rich tissue, which could explain the increase in collagen content found within the extracellular matrix.
The ratio of collagen I/III within the test sites increased over time (Fig. 6b), indicating a continuous remodeling of the ingrown collagen towards a strong connective tissue. The control site showed little or no remodeling after 15 months of implantation, with less collagen type I deposited within the extracellular matrix surrounding the control mesh as opposed to the test site.
This study, which to the best of our knowledge is the longest preclinical evaluation of surgical meshes conducted to date, verifies previous knowledge on the long-term tissue response to polypropylene. The control mesh elicited an acute inflammatory response that is persistent over time, and that turns into a chronic inflammation characterized by foreign-body granulomas surrounding the fibers and a layer of mature collagen, effectively screening the foreign material from the surrounding tissue. Following explantation at 24 and 36 months, the polypropylene mesh was macroscopically not well integrated and was still stiff, and was shown histologically to be encapsulated by well-organized and mature collagen. This corresponds well to previous knowledge of how a host organism protects itself from a foreign object .
TIGR® Matrix Surgical Mesh—the world’s first synthetic long-term resorbable surgical mesh—exhibits a time-dependent mechanical behavior. In this study it elicited an acute and medium-term inflammatory response similar to that of polypropylene, with the important difference that the inflammation declined after 24 months and was practically absent after 36 months. As the matrix degraded completely over 36 months and the inflammatory reaction decreased, a well-remodeled and durable connective tissue replaced the mesh. The collagen layer surrounding the test mesh was thicker and more similar to native connective tissue in its structure as compared to the control mesh.
Considering the comparably low number of control specimens, conclusions should be drawn with caution. It is however evident that there is a substantial difference in the long-term outcome between the test and control mesh when looking at the quantity and quality of the connective tissue that integrates with, or in the case of the test mesh, ultimately replaces the product. We believe these results are due to the differences in mechanical characteristics. A rigid mesh product will absorb the loads by itself and any new connective tissue infiltrate will lack mechanical stimulation, which has been shown to have effects on connective tissue stability [17, 24]. The mechanical behavior of the test mesh was designed to be as closely matched to the tissues where it is to be implanted as practically possible, so that bodily loads could be progressively transferred to the new tissue that is deposited around the mesh and between its fibers. Further studies will be required to investigate this concept of mechanical stimulation of soft tissues more thoroughly. This could potentially lead to a better understanding of soft tissue defects in general, and ultimately to better surgical treatment methods.
Some soft tissue defects that may require surgical intervention, recurrent hernias in particular, are understood to be the result of inadequate ability to form, or maintain adequately, strong connective tissue. Since this study was performed in healthy animals, collagen deficiencies have not been taken into account, which raises the interesting and important question of whether the results shown here would reproduce in a patient population with known collagen diseases or deficiencies. Measuring collagen expression over time following soft tissue repair using TIGR® Matrix in a clinical setting may lead to increased knowledge of this complex situation.
Finally, as no defect recurrences were noted in either the test or control group, and since TIGR® Matrix substantially loses its mechanical strength after 6 months following implantation, the restored tissue is evidently strong enough to carry the abdominal loads in this sheep model. Despite the ongoing discussion regarding the pathology of hernias and other soft tissue defects, we conclude that our findings suggest that TIGR® Matrix Surgical Mesh may represent a new way of utilizing long-lasting, resorbable synthetic polymers that could be of great benefit in soft tissue repair or reinforcement.
The authors would like to thank Per Busch and Kristofer Rubin at the Department of Medical Biochemistry and Microbiology, Uppsala University for valuable contributions to this study. This study was funded by Novus Scientific.